Navigation Links
Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
Date:9/12/2007

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, September 12 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today the company's Chief Scientist Prof. Zvi Bentwich will present AACR's upcoming Molecular Diagnostics in Cancer Therapeutic Development conference. Prof. Bentwich's presentation will focus on Rosetta Genomics unique microRNA-based technologies and current development programs. The event will take place at the Atlanta Hilton, Atlanta.

The presentation, titled, "Human microRNAs: Powerful Biomarkers for Cancer Diagnostics", is part of a plenary session on the molecular classification of tumors, which will be held on Wednesday, September 19, between 10:45 am-1:00 pm.

An audio webcast of the presentation will be made available by AACR 15 days after the conference at the following url: http://www.aacr.org/home/scientists/meetings--workshops/molecular-diagnosti c s-in-cancer-therapeutic-development.aspx

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

About Rosetta Genomics

Rosetta Genomics (Nasdaq:ROSG) is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and various diseases. For more information please visit: http://www.rosettagenomics.com

Contact:

Media

Alan Zachary

T: +1-312-944-6784

media@rosettagenomics.com

Investors

Juliane Snowden

T: +1-212-213-0006

investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Genomics researcher Hood joins NimbleGen board
3. GE Healthcare partners with genomics institute
4. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
5. Wisconsin firms to present at Cleantech venture capital event
6. New Sonic Foundry search engine finds words, phrases in video presentations
7. Lone Wisconsin firm to present at InvestMidwest
8. Sonic Foundry creates search engine for 7,000 expert video presentations
9. InvestMidWest calls for business presentations
10. Wicab to present BrainPort at Boston conference
11. Three more Wisconsin firms to present at venture forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... United States multicenter, prospective clinical study that demonstrates the accuracy of the ... of identifying clinically significant acute bacterial and viral respiratory tract infections by ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):